Deanna Mudie is a Principal Scientist in Research and Development at Lonza's site in Bend, Oregon, USA. Since she joined Lonza in 2016, her focus has been on enabling bioavailability-enhancing amorphous solid dispersions by developing dosage form platforms and in vitro dissolution methodologies to predict bioperformance. Deanna earned her B.S.E. degree in Chemical Engineering and her Ph.D. in Pharmaceutical Sciences from the University of Michigan. She has seven years of predoctoral experience at Pfizer and Merck developing and manufacturing oral dosage forms from preclinical to commercial scale.